Results
1 -
10 of
59Clinical Trials of Novel Antithrombotics: Basic Concepts of Study Design and Methodology, Textbook of Coronary Thrombosis and Thrombolysis Platelet Glycoprotein IIB/IIIA Integrin Inhibition in Acute Myocardial Infarction, Resource Utilization in Cardiac Disease Unstable Angina: PARAGON, PURSUIT, PRISM, and PRISM-PLUS, Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease Unstable Angina Trials, Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease Antithrombotic therapy in acute coronary syndromes, New Approaches to Drug Development The Use of Glycoprotein IIb/IIIa Inhibition in Acute Myocardial Infarction, Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease Glykoprotein-IIb/IIIa-Antagonisten bei akutem koronarem Syndrom, Gerinnungsaktive Therapie beim akuten Koronarsyndrom Therapeutische Inhibition von Thrombozyten, Fach??bergreifende Aspekte der H??mostaseologie III Acute Coronary Syndromes, Coronary Heart Disease in Women Randomized, placebo-controlled study of Lamifiban with thrombolytic therapy for the treatment of acute myocardial infarction: Rationale and design for the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) study, Journal of Thrombosis and Thrombolysis